Posted on August 10th, 2009 in Swine Flu
AstraZeneca’s swine flu research is continuing to combat the mutating forms of the swine flu virus. AstraZeneca’s continuing efforts to produce and distribute the first swine flu vaccine may force it to join venture with top biotech companies participating in the swine flu research. Swine stocks to watch: AVI Biopharma (AVII), Quidel Corporation (QDEL), Novavax (NVAX), BioCryst Pharmaceuticals (BCRX) and Dynavax Technologies (DVAX).
Tags: antiviral, Astra Zeneca, Astrazeneca, AstraZeneca pharmaceuticals, Astrazeneca Swine Flu, Avi biopharma, avii, AZN, AZN.L, BCRX, BioCryst, DVAX, Dynavax, H1N1 virus, influenza virus, MedImmune, Novavax, NVAX, QDEL, Quidel, quidel corp, Quidel Corporation, swine flu antiviral, Swine flu stocks, swine flu stocks to watch, Swine Flu Vaccine, swine flu virus, The swine flu, top biotech companies, Top Pharmaceutical Companies